Literature DB >> 12000225

Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components.

Scott C Dorman1, Clare F Kenny, Lee Miller, Rhoda Elison Hirsch, John P Harrington.   

Abstract

A functional requirement for all hemoglobin-based oxygen carriers (HBOCs) is the maintenance of the heme-iron in the reduced state. This is necessary for the reversible binding/release of molecular oxygen and minimization of methemoglobin (Fe+3) formation. Acellular hemoglobins are especially susceptible to oxidation and denaturation. In the absence of the intrinsic reducing systems of the red blood cell, the reduced heme-Fe+2 can be oxidized to form increasing levels of methemoglobin that can give rise to free radicals and oxidative cellular damage. If acellular HBOCs are to be utilized as red cell substitutes for oxygen delivery, these carriers must be stabilized in the plasma, the carrier medium. Normal plasma contains reducing components, such as ascorbic acid and glutathione, that can afford protection to these acellular HBOCs through electron-transfer mediated processes. For these components to provide effective reduction to an HBOC, a favorable reduction potential difference must exist between the reducing agent and the HBOC. Using a modified thin-layer spectroelectrochemical method, a determination of the formal reduction potential (vs. Ag/AgCl) of several oxygen carriers, including monomeric myoglobin, tetrameric HbA and HbS, chemically cross-linked HbXL99alpha, polymerized oxyglobin (FDA approved for canine anemia), and the natural cross-linked polymeric Lumbricus hemoglobin, have been determined. In contrast to the negative formal reduction potentials (-155 to -50 mV) obtained for Mb, HbA, HbS, HbXL99alpha, and oxyglobin, Lumbricus hemoglobin exhibited a positive formal reduction potential (approximately 100 mV). These results may help explain the greater effectiveness of the tested reducing agents to reduce met Lumbricus hemoglobin, compared to the other HBOCs, back to the required reduced form necessary for physiological binding/release of oxygen. Each reducing agent was capable of reducing met Lumbricus hemoglobin to the fully reduced state, although the kinetics of these reactions were different. HbA, HbXL99alpha, and oxyglobin were only partially reduced (10 to 37%) by glutathione, beta-NADH, and ascorbic acid under similar conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000225     DOI: 10.1081/bio-120002726

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  10 in total

1.  2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules.

Authors:  Anirban Sen Gupta
Journal:  Shock       Date:  2017-09-29       Impact factor: 3.454

2.  Severe acute haemolytic anaemia associated with severe methaemoglobinaemia in a G6PD-deficient man.

Authors:  Abdul Rehman; Mohanad Shehadeh; Diala Khirfan; Akhnuwhkh Jones
Journal:  BMJ Case Rep       Date:  2018-03-28

3.  Modulation of oxidative stability of haemoglobin inside liposome-encapsulated haemoglobin.

Authors:  Vibhudutta Awasthi; Vivek R Yadav; Beth Goins; William T Phillips
Journal:  J Microencapsul       Date:  2012-12-11       Impact factor: 3.142

Review 4.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

5.  Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo.

Authors:  Jacqueline Dunne; Alexis Caron; Patrick Menu; Abdu I Alayash; Paul W Buehler; Michael T Wilson; Radu Silaghi-Dumitrescu; Beatrice Faivre; Chris E Cooper
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

6.  Prevention of the pulmonary vasoconstrictor effects of HBOC-201 in awake lambs by continuously breathing nitric oxide.

Authors:  Binglan Yu; Gian Paolo Volpato; Keqin Chang; Kenneth D Bloch; Warren M Zapol
Journal:  Anesthesiology       Date:  2009-01       Impact factor: 7.892

7.  Biophysical Properties of Lumbricus terrestris Erythrocruorin and Its Potential Use as a Red Blood Cell Substitute.

Authors:  Jacob Elmer; Andre F Palmer
Journal:  J Funct Biomater       Date:  2012-01-06

8.  Evaluating the capacity to generate and preserve nitric oxide bioactivity in highly purified earthworm erythrocruorin: a giant polymeric hemoglobin with potential blood substitute properties.

Authors:  Camille J Roche; Abhinav Talwar; Andre F Palmer; Pedro Cabrales; Gary Gerfen; Joel M Friedman
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

9.  Enzyme-Loaded Nanoreactors Enable the Continuous Regeneration of Nicotinamide Adenine Dinucleotide in Artificial Metabolisms.

Authors:  Seong-Min Jo; Frederik R Wurm; Katharina Landfester
Journal:  Angew Chem Int Ed Engl       Date:  2021-02-25       Impact factor: 15.336

10.  Engineering tyrosine residues into hemoglobin enhances heme reduction, decreases oxidative stress and increases vascular retention of a hemoglobin based blood substitute.

Authors:  Chris E Cooper; Gary G A Silkstone; Michelle Simons; Badri Rajagopal; Natalie Syrett; Thoufieq Shaik; Svetlana Gretton; Elizabeth Welbourn; Leif Bülow; Nélida Leiva Eriksson; Luca Ronda; Andrea Mozzarelli; Andras Eke; Domokos Mathe; Brandon J Reeder
Journal:  Free Radic Biol Med       Date:  2018-12-27       Impact factor: 7.376

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.